Skip to main content
. 2016 Jul 30;21(8):1002. doi: 10.3390/molecules21081002

Table 4.

Examples of the in situ-forming ocular drug delivery systems illustrated above.

Bioactive Polymers Routes of Administration Reference
VEGF inhibitors PNIPAAm Intravitreal (injection) [40]
Fluocinolone acetonide Polyimide Intravitreal (implant) [86]
Fuconazole Gellan gum, carragenan Topical [87]
Bevacizumab Poly (ethylene glycol)-poly (ε-caprolactone)-poly (ethylene glycol) Intracameral [88]